Visual loss complicating OKT3 monoclonal antibody therapy in a renal transplant recipient

Nephrol Dial Transplant. 1995 Nov;10(11):2144-6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blindness / diagnosis
  • Blindness / etiology*
  • Female
  • Graft Rejection / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation / immunology*
  • Muromonab-CD3 / adverse effects*

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3